Suppr超能文献

[慢性肠系膜缺血的血管内治疗:单中心回顾性研究]

[Endovascular management of chronic mesenteric ischemia : retrospective single-centre study].

作者信息

Wirtzfeld N, Assira A, Van Houte B, Vazquez C

机构信息

Service de Chirurgie digestive, CHR du Val de Sambre, Belgique.

Service de Gériatrie, CHR du Val de Sambre, Belgique.

出版信息

Rev Med Liege. 2022 Feb;77(2):98-103.

Abstract

Chronic mesenteric ischemia (CMI) is a clinical entity linked to a gradual decrease in coelio-mesenteric arterial flow caused by occlusive disease of the digestive arterial axes. There are many etiologies of CMI, but most of the time atherosclerosis is the leading cause. Due to the development of collateral networks, clinical manifestations of CMI are very rare although some degree of stenosis of the digestive arteries is frequently found in asymptomatic elderly patients. Symptomatic CMI typically presents with the triad «post-meal abdominal pain - fear of eating - weight loss». Open surgical treatment was the gold standard for the management of symptomatic CMI since 1958. However, from 1980 and the introduction of endovascular treatment, percutaneous angioplasty combined with with stenting became the most common revascularization technique for CMI. The objective of this article is to report the results associated with endovascular therapy in patients with CMI at our hospital over the past 8 years.

摘要

慢性肠系膜缺血(CMI)是一种临床病症,与消化动脉轴闭塞性疾病导致的腹腔 - 肠系膜动脉血流逐渐减少有关。CMI有多种病因,但大多数情况下动脉粥样硬化是主要原因。由于侧支网络的发展,尽管在无症状老年患者中经常发现一定程度的消化动脉狭窄,但CMI的临床表现非常罕见。有症状的CMI通常表现为“餐后腹痛 - 畏食 - 体重减轻”三联征。自1958年以来,开放手术治疗一直是有症状CMI治疗的金标准。然而,自1980年引入血管内治疗以来,经皮血管成形术联合支架置入术已成为CMI最常用的血管重建技术。本文的目的是报告我院过去8年中CMI患者血管内治疗的相关结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验